AzTrials
AzTrials

Target Controlled Infusion (TCI)Phase 4NCT02135016

The Effect of Thoracic Epidural Anesthesia With Different Block Level on Propofol Induction

A Phase 4 study testing 1% lidocaine, 2% lidocaine and 0.9% normal saline in people with Target Controlled Infusion (TCI) and Thoracic Epidural Anesthesia, run by First Hospital of China Medical University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

It is a prospective, randomized, placebo-controlled study to investigate the effect of TEA with different block level on propofol concentration during general anesthesia induction. Read more about this study

Who is it for?
Ages 40 to 60 years
What is being tested?
1% lidocaine, 2% lidocaine and 0.9% normal saline
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
45 participants
Where
1 siteChina
Study dates
Apr 2014to Jul 2014
Phase
Phase 4
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • American Society of Anesthesiologists (ASA) I-II physical status,
  • aged 40-60 yr,
  • BMI 19-25 kg/m2,
  • undergoing elective gastrointestinal surgery

Who cannot join

  • patients with cardiovascular or neurological disease, drug or alcohol abuse and absolute contraindications for neuraxial blockade.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Jun Wang

    Shenyang, Liaoning

Other trials in China

About this study

Official title: The Effect of Thoracic Epidural Anesthesia With Different Block Level on Propofol Concentration During General Anesthesia Induction

It is a prospective, randomized, placebo-controlled study to investigate the effect of TEA with different block level on propofol concentration during general anesthesia induction.

Being tested
1% lidocaine, 2% lidocaine, 0.9% normal saline
Keywords
effect-site concentration, propofol, thoracic epidural anesthesia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 1% lidocaineDrug

    Also called A

    epidural anesthesia with 1% lidocaine 10ml before propofol TCI

  • 2% lidocaineDrug

    Also called B

    epidural anesthesia with 2% lidocaine 5ml before propofol TCI

  • 0.9% normal salineDrug

    Also called C

    epidural anesthesia with 0.9% normal saline 5ml before propofol TCI

Study groups in NCT02135016
Study groupRoleWhat they receive
1% lidocaineExperimentalepidural anesthesia with 1% lidocaine 10ml before propofol TCI
Receives: Drug: 1% lidocaine
2% lidocaineExperimentalepidural anesthesia with 2% lidocaine 5ml before propofol TCI
Receives: Drug: 2% lidocaine
0.9% normal salinePlacebo comparatorepidural anesthesia with 0.9% normal saline 5ml before propofol TCI
Receives: Drug: 0.9% normal saline

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Effect-site Concentration of Propofol

    The effect-site concentration of propofol when loss of consciousness during propofol target-controlled infusing(TCI) induction of anesthesia.

    Measured: The participants will be followed for the duration of anesthesia induction, an expected average of half an hour

Secondary outcomes (4)
  1. The Bispectral Index

    The bispectral index (BIS) of each patient will be recorded at four different time points,as follows, baseline(the awake phase before epidural anesthesia),10 mins after epidural anesthesia, 20 mins after epidural anesthesia, loss of consciousness(when the participants are lost eyelash reflex during propofol TCI induction of anesthesia). BIS values varies from 0 to 100(0, no cerebral activity; 40 to 60, general anesthesia; 60 to 85, sedated; 85 to 100, awake).

    Measured: The participants will be followed for the duration of anesthesia induction, an expected average of half an hour

  2. The Mean Blood Pressure

    The mean arterial pressure of each patient will be recorded at four different time points, as follows, baseline(the awake phase before epidural anesthesia), 10 mins after epidural anesthesia, 20 mins after epidural anesthesia, loss of consciousness(when the participants are lost eyelash reflex during propofol TCI induction of anesthesia).

    Measured: The participants will be followed for the duration of anesthesia induction, an expected average of half an hour

  3. The Heart Rate

    The heart rate of each patient will be recorded at three different four points, as follows, baseline(the awake phase before epidural anesthesia), 10mins after epidural anesthesia, 20 mins after epidural anesthesia, loss of consciousness(when the participants are lost eyelash reflex during propofol TCI induction of anesthesia).

    Measured: The participants will be followed for the duration of anesthesia induction, an expected average of half an hour

  4. The Block Level of Epidural Anesthesia

    The block level 20mins after epidural anesthesia and it is verified by the loss of sensation to alcohol swab before target controlled infusion of propofol.It is the number of block segments.The block level varies from 0 to 10(0, no block level; 1 to 5, narrow block level;6 to 10, wide block level).

    Measured: 20 mins after epidural anesthesia

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 May 2014 (estimated)
  2. Study startApr 2014
  3. Primary completionJul 2014
  4. Study completionJul 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
45 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02135016
Sponsor's protocol ID
20140415
Status last verified
Aug 2014
First submitted
30 Apr 2014
Last updated
29 Aug 2014
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing 1% lidocaine, 2% lidocaine and 0.9% normal saline in people with Target Controlled Infusion (TCI) and Thoracic Epidural Anesthesia, run by First Hospital of China Medical University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Aug 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Yes. Results are posted in the registry (first posted 29 Aug 2014). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Effect-site Concentration of Propofol (time frame: The participants will be followed for the duration of anesthesia induction, an expected average of half an hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Aug 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in